CFO of Cytori Therapeutics Inc (CYTX, Financial) Mark E Saad buys 6,000 shares of CYTX on 05/21/2010 at an average price of $4.29 a share.
Cytori Therapeutics Inc has a market cap of $185.1 million; its shares were traded at around $4.32 with and P/S ratio of 31.7.
Cytori Therapeutics Inc has a market cap of $185.1 million; its shares were traded at around $4.32 with and P/S ratio of 31.7.
Directors and Officers Recent Trades:
- Buy:: Director Paul W Hawran bought 5,000 shares of CYTX stock on 05/19/2010 at the average price of 4.83, the price of the stock has decreased by 10.56% since.
- Buy:: Director Paul W Hawran bought 5,000 shares of CYTX stock on 11/25/2009 at the average price of 4.9, the price of the stock has decreased by 11.84% since.
- Buy:: Director Paul W Hawran bought 5,000 shares of CYTX stock on 11/24/2009 at the average price of 4.74, the price of the stock has decreased by 8.86% since.
- Sell:: Director E Carmack Holmes sold 20,000 shares of CYTX stock on 01/20/2010 at the average price of 9.06, the price of the stock has decreased by 52.32% since.
